TG Therapeutics, Inc.
TGTX·88322Q108·US·Common Stock·Healthcare - Biotechnology-13D/G
TGTX (TG Therapeutics, Inc.) is held by 182 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($1.2B), VANGUARD PORTFOLIO MANAGEMENT LLC ($437.5M), STATE STREET CORP ($427.8M). Net institutional sentiment: Mixed.
182
Holders
(10 Elite)
$5.4B
Total Value
63% (185)
Consensus
117 buying - 68 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Nov 25, 2025 · Activists Apr 29, 2026 · Congress none
InsiderEYEchelard YannSell $163KNov 24, 2025
Checking access…
Top Holders
Checking access…
Showing 1-20 of 190
1 / 10
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer